Halothiophene benzimidazoles as P1 surrogates of inhibitors of blood coagulation factor Xa
- 16 July 2004
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (14), 3763-3769
- https://doi.org/10.1016/j.bmcl.2004.04.097
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- A general synthesis of 1-aryl carbamoyl-2-alkyl-4-aryl substituted semicarbazides as nonbasic factor Xa inhibitorsBioorganic & Medicinal Chemistry Letters, 2003
- The Use of 3D Structural Data in the Design of Specific Factor Xa InhibitorsCurrent Topics in Medicinal Chemistry, 2001
- Perspectives on Factor Xa InhibitionCurrent Medicinal Chemistry, 2001
- Discovery of 1-[3-(Aminomethyl)phenyl]-N-[3-fluoro-2‘-(methylsulfonyl)- [1,1‘-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a Highly Potent, Selective, and Orally Bioavailable Inhibitor of Blood Coagulation Factor XaJournal of Medicinal Chemistry, 2001
- Non-Amidine-Containing 1,2-Dibenzamidobenzene Inhibitors of Human Factor Xa with Potent Anticoagulant and Antithrombotic ActivityJournal of Medicinal Chemistry, 2000
- 2.Endothelin antagonists: Evaluation of 2,1,3-benzothiadiazole as a methylendioxyphenyl bioisosterBioorganic & Medicinal Chemistry Letters, 1998
- Synthesis and biological activities of meribendan and related heterocyclic benzimidazolo-pyridazinonesEuropean Journal of Medicinal Chemistry, 1993